Ejaculatory Duct Cyst
An ejaculatory duct cyst is a fluid-filled sac arising from one of the paired ducts that carry sperm and seminal fluid through the prostate to the urethra. Most are small, cause no symptoms, and are discovered incidentally on MRI or ultrasound performed for another reason—commonly during evaluation of a raised PSA or a prostate nodule. A minority become large enough to obstruct the duct, and these can cause painful ejaculation, blood in the semen, reduced ejaculate volume, pelvic discomfort, or infertility from obstruction of sperm outflow. The main clinical task is distinguishing them from other cystic lesions in the same region, particularly midline müllerian and utricle cysts, since the distinction affects both what the finding means and how it is treated.
What is it?
Sperm produced in the testes travel up the vas deferens, which joins the duct of the seminal vesicle on each side to form the ejaculatory duct. These paired ducts—each only about two centimetres long—run forward and downward through the substance of the prostate and open into the urethra at a small elevation called the verumontanum. They are the final common pathway through which sperm and seminal fluid reach the urethra at ejaculation.
An ejaculatory duct cyst is a fluid-filled sac arising from one of these ducts. Because the ducts are paired structures lying just off the midline, these cysts are characteristically paramedian—positioned slightly to one side—which is one of the features that distinguishes them from other cysts in the region.
Cysts here arise in two broad ways. Congenital cysts result from developmental abnormality of the duct, such as atresia or a segment of the duct failing to canalise properly. Acquired cysts result from obstruction, in which the duct becomes blocked and the segment behind the blockage dilates into a cyst. Causes of acquired obstruction include prior infection or inflammation, calculi within the duct, scarring after instrumentation or surgery, and compression by an enlarging prostate.
Understanding the differential is central here, because the prostate and its surroundings host several types of cyst that look broadly similar to a patient reading a report but differ meaningfully in origin and significance.
Midline cysts include müllerian duct cysts and prostatic utricle cysts. Both sit in the midline behind the prostate and arise from remnants of embryonic structures. Müllerian duct cysts derive from incomplete regression of the müllerian ducts, do not communicate with the urethra, and typically contain no sperm. Utricle cysts arise from the prostatic utricle, may communicate with the urethra, are associated with hypospadias and other genitourinary anomalies, and are more often identified in younger patients. The distinction between these two is sometimes debated even among specialists, and reports occasionally use the terms interchangeably.
Ejaculatory duct cysts, by contrast, are paramedian rather than midline, communicate with the ejaculatory duct system, and characteristically contain sperm on aspiration—a finding that essentially confirms the diagnosis.
Prostatic retention cysts are common, arise from obstructed prostatic glands, are usually small, occur anywhere in the gland, and are of no significance. Cysts associated with benign prostatic hyperplasia are similarly common and incidental.
Seminal vesicle cysts arise in the vesicles themselves rather than the ducts, sit higher and further from the midline, and carry an important association: unilateral seminal vesicle cysts are frequently accompanied by ipsilateral renal agenesis or dysplasia, a combination sometimes referred to as Zinner syndrome. Identifying one should prompt assessment of the kidneys.
Less commonly, cystic change can reflect an abscess, a hydatid or parasitic cyst in endemic regions, or—rarely—a cystic tumour, which is why lesions with solid components, thick irregular walls, or internal enhancement are assessed more carefully rather than assumed benign.
Most ejaculatory duct cysts cause no symptoms whatsoever and are found incidentally, often on an MRI performed to evaluate a raised PSA or a palpable nodule. For these, the finding is simply an anatomical variant of no consequence.
When cysts do cause symptoms, the pattern reflects obstruction or irritation of the duct.
Painful ejaculation is among the more characteristic complaints and is worth taking seriously, since it is otherwise uncommon and has a relatively limited differential.
Haematospermia—blood in the semen—can occur, sometimes recurrently. It is worth noting that haematospermia has many causes, most of them benign, and in men under 40 without other features it is usually self-limiting. In men over 40, or where it persists or recurs, evaluation is appropriate.
Reduced ejaculate volume occurs when the duct is obstructed, and can be marked when obstruction is complete and involves both sides, since the seminal vesicles contribute the majority of ejaculate volume.
Infertility can be the presenting feature. Ejaculatory duct obstruction produces a recognisable pattern on semen analysis: low ejaculate volume, low or absent sperm count, low fructose, and acidic pH—the last two because the alkaline, fructose-rich seminal vesicle contribution is not reaching the ejaculate. This combination should prompt imaging, since it points to an obstructive rather than a productive cause, and obstructive causes are potentially correctable.
Pelvic, perineal, or testicular discomfort, often worse after ejaculation, and recurrent epididymitis or prostatitis-like symptoms occur in some men.
Urinary symptoms arise when a cyst is large enough to press on the urethra or bladder base, producing hesitancy, frequency, or urgency.
Evaluation is imaging-based and focuses on characterising the cyst and identifying whether it explains the symptoms.
MRI of the prostate is the most informative test. It defines the cyst’s precise position relative to the midline, its relationship to the ejaculatory ducts, seminal vesicles, and urethra, its size, and its contents. Simple fluid appears characteristically bright on T2-weighted images; blood products, protein, or debris alter the appearance and can indicate prior haemorrhage or infection. MRI also identifies associated findings including dilated seminal vesicles or vas deferens, which support obstruction, and it assesses the prostate itself for any coexisting abnormality.
Transrectal ultrasound is well suited to this region, is widely available, and is often the initial test. It demonstrates cysts, assesses seminal vesicle dilation, and can be used to guide aspiration or drainage.
CT identifies larger cysts but characterises them poorly and generally cannot distinguish among the cyst types, so it is not the test of choice.
Semen analysis is essential when infertility or obstruction is suspected, and the pattern described above is highly suggestive of ejaculatory duct obstruction.
Aspiration of cyst fluid under ultrasound guidance is both diagnostic and sometimes therapeutic. Finding sperm in the aspirate confirms that the cyst communicates with the ejaculatory duct system and distinguishes it from a müllerian cyst.
Vasography and other contrast studies of the duct system are used less often now, having been largely superseded by MRI, but retain a role in selected assessments.
Features that prompt closer evaluation rather than reassurance include a cyst with solid components or nodularity, thick or irregular walls, internal enhancement after contrast, rapid growth, or associated symptoms that do not fit a simple obstructive picture.
Important to Know
The most important practical point is that a small ejaculatory duct cyst found incidentally on a scan, in a man without symptoms, requires no treatment and no follow-up. This is a common situation, and the finding often appears in a report alongside the abnormality the scan was actually looking for. Care is typically coordinated by urologists, with reproductive medicine involvement where fertility is a concern.
Reassurance is the appropriate outcome for the majority. Small, simple, thin-walled cysts with uniform fluid content and no associated obstruction are benign anatomical findings. There is no evidence that they progress, become malignant, or require monitoring, and no dietary, lifestyle, or medical measure is relevant.
Where symptoms are present, the first step is establishing whether the cyst actually explains them. Painful ejaculation, haematospermia, and pelvic discomfort all have other causes, and the presence of a cyst does not automatically make it the culprit. Attributing symptoms to an incidental cyst can lead to an unnecessary procedure while the real cause goes unaddressed. Semen analysis, assessment for infection, and careful correlation between the cyst’s position and the symptom pattern all inform this judgement.
Transurethral resection of the ejaculatory ducts is the main interventional treatment for symptomatic obstruction. Performed endoscopically through the urethra, it unroofs the obstructed duct or cyst at the verumontanum, restoring outflow. It can substantially improve semen parameters in men with obstruction, and a meaningful proportion achieve improved ejaculate volume and sperm count, with natural conception possible in some couples. Results vary considerably depending on the cause and completeness of obstruction, and men should have realistic expectations rather than assuming a procedure guarantees fertility.
Complications of this procedure deserve mention because they influence the decision. Retrograde ejaculation—semen passing backwards into the bladder—is the most common, and reflux of urine into the ejaculatory ducts and seminal vesicles can occur, sometimes causing recurrent infection or persistent symptoms. Epididymitis, and rarely injury to the urinary sphincter or rectum, are further risks. These are the reason intervention is reserved for men with genuine symptoms or fertility goals rather than offered for an incidental finding.
Transrectal ultrasound-guided aspiration is a less invasive alternative used in selected cases, though cysts frequently refill and the benefit may be temporary. It has a useful diagnostic role regardless, since finding sperm confirms the diagnosis.
For men whose primary concern is fertility, it is worth understanding that intervention is not the only route. Assisted reproductive techniques using sperm retrieved directly from the testis or epididymis bypass the obstruction entirely and are highly effective. The choice between attempting to correct the obstruction and proceeding directly to assisted reproduction depends on the specific anatomy, the partner’s fertility assessment, and the couple’s priorities, and is best discussed with a reproductive urologist.
Associated infection is treated with antibiotics, sometimes for an extended course, and a cyst that becomes infected may require drainage.
A specific point about Zinner syndrome is worth carrying: when a seminal vesicle cyst is identified—as opposed to an ejaculatory duct cyst—the kidneys should be assessed, since absence or dysplasia of the kidney on the same side is a recognised association. The two cyst types are sometimes confused, so it is reasonable to clarify which has been described.
Follow-up is generally unnecessary for asymptomatic cysts. Men treated for symptomatic obstruction are followed with symptom assessment and, where relevant, repeat semen analysis to gauge response.
Care is typically coordinated by urology, with reproductive medicine, radiology, and infectious disease input as needed. Imaging, semen analysis, and clinical findings are interpreted alongside the man’s symptoms, fertility goals, and broader clinical context rather than in isolation.
Patient education plays an important role, largely because these findings are unfamiliar and can sound alarming on a report. Understanding that most such cysts are harmless incidental findings, that they are not cancerous and do not become cancerous, that treatment exists but is reserved for genuine symptoms, that obstruction-related infertility is often correctable, and which symptoms warrant evaluation all contribute to appropriate care and prevent unnecessary anxiety.
Red flag symptoms include inability to pass urine, which is a urological emergency; fever with pelvic or perineal pain suggesting infection or abscess; persistent or recurrent blood in the semen, particularly in men over 40; blood in the urine; a rapidly enlarging pelvic mass; severe or worsening pelvic pain; and persistent painful ejaculation. These warrant medical evaluation, urgently where infection or urinary retention is suspected.